These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15341946)

  • 1. Discovery of orally active prostaglandin D2 receptor antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4891-5. PubMed ID: 15341946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem; 2004 Oct; 12(20):5361-78. PubMed ID: 15388164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Masaaki Toda
    Bioorg Med Chem; 2004 Sep; 12(17):4685-700. PubMed ID: 15358295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a prostaglandin D2 receptor antagonist: discovery of a new chemical lead.
    Torisu K; Kobayashi K; Iwahashi M; Egashira H; Nakai Y; Okada Y; Nanbu F; Ohuchida S; Nakai H; Toda M
    Eur J Med Chem; 2005 May; 40(5):505-19. PubMed ID: 15893024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of selective indole-based prostaglandin D₂ receptor antagonist.
    Iwahashi M; Shimabukuro A; Onoda T; Matsunaga Y; Okada Y; Matsumoto R; Nambu F; Nakai H; Toda M
    Bioorg Med Chem; 2011 Aug; 19(15):4574-88. PubMed ID: 21737285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new chemical leads for prostaglandin D2 receptor antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Egashira H; Nakai Y; Okada Y; Nanbu F; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4557-62. PubMed ID: 15357992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new orally active prostaglandin D2 receptor antagonists.
    Iwahashi M; Naganawa A; Kinoshita A; Shimabukuro A; Nishiyama T; Ogawa S; Matsunaga Y; Tsukamoto K; Okada Y; Matsumoto R; Nambu F; Oumi R; Odagaki Y; Katagi J; Yano K; Tani K; Nakai H; Toda M
    Bioorg Med Chem; 2011 Nov; 19(22):6935-48. PubMed ID: 21982795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane derivatives.
    Mitsumori S; Tsuri T; Honma T; Hiramatsu Y; Okada T; Hashizume H; Kida S; Inagaki M; Arimura A; Yasui K; Asanuma F; Kishino J; Ohtani M
    J Med Chem; 2003 Jun; 46(12):2446-55. PubMed ID: 12773048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2.2.1]heptane derivatives.
    Mitsumori S; Tsuri T; Honma T; Hiramatsu Y; Okada T; Hashizume H; Inagaki M; Arimura A; Yasui K; Asanuma F; Kishino J; Ohtani M
    J Med Chem; 2003 Jun; 46(12):2436-45. PubMed ID: 12773047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis.
    Stearns BA; Baccei C; Bain G; Broadhead A; Clark RC; Coate H; Evans JF; Fagan P; Hutchinson JH; King C; Lee C; Lorrain DS; Prasit P; Prodanovich P; Santini A; Scott JM; Stock NS; Truong YP
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4647-51. PubMed ID: 19608418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
    Crosignani S; Prêtre A; Jorand-Lebrun C; Fraboulet G; Seenisamy J; Augustine JK; Missotten M; Humbert Y; Cleva C; Abla N; Daff H; Schott O; Schneider M; Burgat-Charvillon F; Rivron D; Hamernig I; Arrighi JF; Gaudet M; Zimmerli SC; Juillard P; Johnson Z
    J Med Chem; 2011 Oct; 54(20):7299-317. PubMed ID: 21916510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation.
    Bain G; Lorrain DS; Stebbins KJ; Broadhead AR; Santini AM; Prodanovich P; Darlington J; King CD; Lee C; Baccei C; Stearns B; Troung Y; Hutchinson JH; Prasit P; Evans JF
    J Pharmacol Exp Ther; 2011 Jul; 338(1):290-301. PubMed ID: 21487069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.
    Ulven T; Receveur JM; Grimstrup M; Rist Ø; Frimurer TM; Gerlach LO; Mathiesen JM; Kostenis E; Uller L; Högberg T
    J Med Chem; 2006 Nov; 49(23):6638-41. PubMed ID: 17154491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
    Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R
    J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of prostaglandin D2 via prostanoid DP receptor to nasal hyperresponsiveness in guinea pigs repeatedly exposed to antigen.
    Yasui K; Asanuma F; Hirano Y; Shichijo M; Deguchi M; Arimura A
    Eur J Pharmacol; 2008 Jan; 578(2-3):286-91. PubMed ID: 17927976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.
    Sandham DA; Adcock C; Bala K; Barker L; Brown Z; Dubois G; Budd D; Cox B; Fairhurst RA; Furegati M; Leblanc C; Manini J; Profit R; Reilly J; Stringer R; Schmidt A; Turner KL; Watson SJ; Willis J; Williams G; Wilson C
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4794-8. PubMed ID: 19592244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
    Beaulieu C; Guay D; Wang Z; Leblanc Y; Roy P; Dufresne C; Zamboni R; Berthelette C; Day S; Tsou N; Denis D; Greig G; Mathieu MC; O'Neill G
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2696-700. PubMed ID: 18359630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroquinoline derivatives as CRTH2 antagonists.
    Liu J; Wang Y; Sun Y; Marshall D; Miao S; Tonn G; Anders P; Tocker J; Tang HL; Medina J
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6840-4. PubMed ID: 19896843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzimidazoles as new potent and selective DP antagonists for the treatment of allergic rhinitis.
    Beaulieu C; Wang Z; Denis D; Greig G; Lamontagne S; O'Neill G; Slipetz D; Wang J
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3195-9. PubMed ID: 15149674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel and potent CRTH2 antagonists.
    Ito S; Terasaka T; Zenkoh T; Matsuda H; Hayashida H; Nagata H; Imamura Y; Kobayashi M; Takeuchi M; Ohta M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1194-7. PubMed ID: 22178554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.